This study aims to evaluate the aberrant expression, molecular functions, prognostic value, and related mechanisms of RMI2 in breast cancer, and to provide a fundamental for molecular diagnosis and clinical therapy of breast cancer. Here, RMI2 is linked to breast carcinoma.